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ORIGINAL ARTICLE
Antidiabetic effects of Mukia maderaspatana and its phenolics:
An in vitro study on gluconeogenesis and glucose uptake in rat tissues
B. R. Srilatha and S. Ananda
Department of Studies in Chemistry, University of Mysore, Manasagangothri, Mysore, Karnataka, India
Abstract
Context: Traditional medicine is used by over 60% of the world’s population for health care.
Mukia maderaspatana (L.) M. Roem. (Cucurbitaceae) (Mukia) is extensively used in folklore
medicine as an antidiabetic plant. It is rich in phenolics that contribute to its medicinal
properties.
Objective:Mukia extract and phenolics such as quercetin and phloroglucinol are investigated for
their in vitro antidiabetic activity.
Materials and methods: Quercetin, phloroglucinol, and methanol extract of the dried whole
plant (0.25 and 0.5mg/ml) were studied for the inhibition of gluconeogenesis in rat liver slices
and glucose uptake in isolated rat hemi-diaphragm (50 and 100 mg/ml). Phenolics of Mukia
were analyzed by HPLC.
Results and discussion: Glucose (1.2mg/g/h) was synthesized from pyruvate and the synthesis
was completely inhibited by insulin (1 U/ml). Quercetin at 0.25 and 0.5mg/ml caused 65%
and 89% inhibition (0.42mg/g/h and 0.13mg/g/h glucose). Addition of insulin did not
increase inhibition. Phloroglucinol inhibited 100% glucose production with or without insulin.
Mukia (0.25mg/ml) inhibited gluconeogenesis (0.65mg/g/h) by 45%, and with insulin,
inhibition increased to 50% (0.59mg/g/h). At 0.5mg/ml, glucose production was stimulated
by1.2-fold, but with insulin it was inhibited by 89% (0.13mg/g/h glucose). Mukia had no effect
on glucose uptake, but potentiated the action of insulin mediated glucose uptake
(152.82 13.30mg/dl/g/30min) compared with insulin control (112.41 9.14mg/dl/g/30min)
(p50.05). HPLC analysis revealed the presence of phenolics.
Conclusion: Results provide scientific rationale for the use of Mukia in folk medicine as an
antidiabetic nutraceutical.
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Introduction
Diabetes mellitus is a single most prevalent disease and a
major cause of mortality and morbidity worldwide. It is
estimated that there are over 350 million diabetics globally,
and of them, over 90% have type 2 diabetes (Shaw et al.,
2000). Type 2 diabetes represents a syndrome with disturb-
ances in the metabolism of carbohydrates and fats and is also
characterized by insulin resistance, especially in the muscle,
adipose, and liver. Insulin resistance results in excess glucose
output in the liver and impaired glucose utilization in muscle
and peripheral tissues.
A change in lifestyle is at the forefront of management of
type 2 diabetes, which includes exercise, weight control,
and medical nutrition therapy (Nathan et al., 2006). Patients
who are unable to achieve glucose homeostasis by diet
and exercise are given oral antidiabetic drugs as a part of
the conventional therapy. There are five classes of oral
antidiabetic agents, namely, biguanides, sulphonylureas,
a-glucosidase inhibitors, thiozolidine diones, and megliti-
nides. All these drugs have side effects (De Fonzo, 1999).
Hence medicinal plants have increasingly becoming popular
in the last several years as an alternate therapy (Dey et al.,
2002). They have the same degree of efficacy as the
antidiabetic drugs, but without the side effects. Moreover,
many of the present day antidiabetic drugs were derived from
medicinal plants. For example, metformin was synthesized
based on the use of Glega officinalis (Linn.) (Fabaceace) to
treat diabetes (Cusi & Defronzo, 1998).
Over 400 traditional plant-based antidiabetic therapies
have been reported (Guptha et al., 2008). However, only a
very few of them have been investigated scientifically to
assess their efficacy. The physiological effects of plants and
their extracts are because of the presence of specific
phytochemicals in them. The phytochemicals such as phen-
olics (Yao et al., 2012), flavonoids (Chang et al., 2012),
alkaloids (Sharma et al., 2010), and terpenoids (Periyasamy
et al., 2012) possess diverse biological properties making
them attractive candidates for therapeutic applications
(Alexiou & Demopoulos, 2010). Mukia maderaspatna (L.)
M. Roem. (Cucurbitaceae), commonly known as Madras pea
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pumpkin, is one such plant. It is a hepatoprotective
(Thabrew et al., 1995), an anti-inflammatory, antiarthiritic
(Ramakrishnamacharya et al., 1996), and antihypertensive
agent and showed beneficial effects on lipid profile, fibrino-
gen, bilirubin, and body mass index in human volunteers
(Raja et al., 2007). It is eaten as a leafy vegetable and
traditionally used in antidiabetic therapy in some parts of
India. It is rich in phenolics that contribute to its biological
and medicinal properties.
In the present study, the in vitro antidiabetic effects of
the methanol extract of M. maderaspatana (Mukia extract)
and phytochemicals such as quercetin and phloroglucinol
were studied. Their effect on gluconeogenesis in the rat
liver tissues and glucose uptake in the isolated rat hemi-
diaphragm are presented. The antidiabetic effects of the
Mukia extract are compared with those of insulin, quercetin,
and phloroglucinol. The HPLC analysis was also carried out
for the extract to identify and quantify the phenolic
constituent(s).
Materials and methods
Chemicals
Quercetin and phloroglucinol were purchased from Sigma-
Aldrich (Bangalore, India). Sodium pyruvate and glucose
were purchased from SR Laboratories (Mumbai, India).
Hank’s Balanced Salt Solution (HBSS) and Tyrode-Ringer
buffer were purchased from Hi-Media Laboratories (Mumbai,
India). Glucose oxidase and peroxidase (GOD/POD) assay kit
was purchased from AUTO SPAN Diagnostics (Mumbai,
India). Human Insulin was purchased from Nova Nordisk
(Bangalore, India). All other chemicals and reagents were
purchased from SR Laboratories and Hi-Media Laboratories,
and were of analytical grade.
Plant material and preparation of plant extract
The whole plant was collected from the Hassan district of
Karnataka during the month of June, authenticated by botanist
Dr. M.S. Sudarshana, University of Mysore. A voucher
specimen (BOT-003-2010) has been deposited at the Botany
Herbarium, University of Mysore, Mysore. The edible parts of
the whole plant (leaves, stem and roots) were shade-dried and
pulverized using a mechanical grinder. The powdered plant
material (50 g) was extracted with methanol (200 ml) in a
Soxhlet apparatus for 24 h. Solvent extract was filtered
through Whatman No. 1 filter paper and the filtrate was
evaporated to dryness using a rotary evaporator at 40 C,
which yielded a crude extract of 10% w/w. The dried extract
was kept at 20 C until further analysis.
Sequential extraction of plant material for HPLC
analysis
The dried powder of whole plant material (50 g) was
subjected to sequential Soxhlet extraction with solvents of
increasing polarity such as petroleum ether (6080 C),
chloroform, ethyl acetate, and finally with methanol, for 24 h.
Each solvent extract was collected separately and filtered
through Whatman No. 1 filter paper and the filtrate was
evaporated to dryness using the rotary evaporator at 40 C to
yield crude extracts. The dried extracts were weighed and
stored at 20 C till further analysis.
HPLC analysis of Mukia extract
HPLC analysis of the different solvent extracts was carried
out by the ISO method (ISO, 2005) for the identification of
phenolics. Analysis were performed using an Agilent 1260
infinity series HPLC system comprising an autosampler
(G13118), DI diode array detector (G4212B), and Agilent
Eclipse Plus phenyl-hexyl column (4.6 250 mm, 5 mm).
Samples or standards prepared in methanol (1 mg/ml) were
injected in triplicate (20 ml) to the column. The mobile phase
A consisted of 9% (volume fraction) acetonitrile, 2% (volume
fraction) acetic acid with 20 mg/ml EDTA and mobile B
consisted 80% (volume fraction) acetonitrile, 2% (volume
fraction) acetic acid with 20 mg/ml EDTA. Separation was
carried out at a 1 ml/min flow rate with an HPLC column
maintained at 37 C and a detection at 278 nm. HPLC analysis
was carried out using a gradient elution. Binary gradient
conditions: 100% mobile phase A for 10 min, then over
15 min, a linear gradient to 68% mobile phase A and 32%
mobile phase B and held at this composition for 10 min. Then,
reset to 100% mobile phase A over the next 5 min followed by
10 min equilibration before next injection.
Animals
Male albino rats weighing between 200 and 300 g were taken
for the study from the Central Animal Facility, University of
Mysore, Mysore. The animals were fed standard laboratory
diet and water ad libitum and housed at room temperature.
The rats were fasted overnight with free access to water prior
to carrying out the in vitro experiments.
In vitro gluconeogenesis assay
Adult male albino rats were fasted overnight and were killed
by cervical dislocation. The liver was excised and washed in
ice cold saline and stored on ice. Liver slices were made as
described by Peng et al. (1973) and Roobol and Alleyne
(1972). The slices were weighed in a digital balance. The
weights of tissue slices were between 100 and 150 mg. They
were transferred to culture dishes containing Hank’s Balanced
Salt Solution (HBSS). Sodium pyruvate (10 mM) prepared in
HBSS was added to the culture dish such that the final
concentration of the pyruvate was 5 mM. The culture dishes
were incubated at ambient temperature (27 C) for up to
60 min. Aliquots were taken from the medium at 0, 30, and
60 min. The amount of glucose formed in the culture dish was
assayed using the GOD–POD method described below.
Effect of insulin, phytochemicals and Mukia extract on
in vitro gluconeogenesis
Gluconeogenesis in the liver was carried out as described
above in the presence of 1 Unit (1 U) and 2 Units (2 U)
of insulin (Nova Nordisk, Bangalore, Karnataka, India)
added prior to the addition of pyruvate. Quercetin (0.25 and
0.5 mg/ml), phloroglucinol (0.25 and 0.5 mg/ml), and Mukia
extract (0.25 and 0.5 mg/ml) were preincubated for 5 min
individually with the liver slices before initiating
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gluconeogenesis in the absence and presence of 1 U of
insulin. Gluconeogenesis from pyruvate in the pre-treated
liver slices was determined as described above.
In vitro glucose uptake by isolated rat
hemi-diaphragm
Glucose uptake in isolated rat hemi-diaphragm was estimated
essentially by the method described by Walaas and Walaas
(1952) with some modifications (Chattopadhya et al., 1992).
The glucose uptake studies were carried out using the rat-
isolated hemi-diaphragm in Tyrode’s solution containing 0.2%
glucose. The glucose left over in the culture tubes after 30 min
incubation at 37 C in an atmosphere of 100% oxygen was
determined as described below. Adult male albino rats were
fasted overnight and killed by decapitation. The diaphragms
were dissected quickly. The diaphragm isolated from each rat
was divided into two equal halves. The isolated hemi-
diaphragms were then rinsed in cold Tyrode’s solution
(without glucose) to remove any blood clot and weighed in
a digital balance. The two halves of the hemi-diaphragms
from the same rat were not used for the same set of
experiments, but were used for two different set of experi-
ments. The glucose uptake was determined using the isolated
rat hemi-diaphragm (Tyrode solution with 0.2% glucose) in
the presence of 0.4 units/ml of insulin (Nova Nordisk), 50 and
100mg/ml of Mukia extract, and in the presence of both
insulin (0.4 units/ml) and Mukia extract (100 mg/ml). The
uptake was compared with normal control diaphragms that
contained only glucose in Tyrode’s solution. A total of five
groups with eight sets in each group were compared.
Milligram of glucose taken up per gram of rat hemi-
diaphragm/30 min was calculated. The results are expressed
as mean standard deviation (SD) (n¼ 8).
Glucose assay by GOD–POD method
Glucose in the culture dishes/tubes was assayed by the
GOD–POD assay kit protocol. Briefly, 50 ml of the incubated
medium was transferred to a 96-well ELISA plate. The color
reagent (200 ml) was added to each well. The color was
developed in the dark at RT for 30 min and then the optical
density was measured at 505 nm.
Statistical analysis
Results are expressed as mean SD. The means between two
groups were compared using Student’s t test, assuming equal
variance among the groups and differences were considered
statistically significant at p50.05.
Results
Sequential extraction of plant material for HPLC
analysis
The yield of the different solvent extracts per gram of dry
material was as follows: petroleum ether 36.6 mg/g, chloro-
form 27.8 mg/g, ethyl acetate 12.0 mg/g, and methanol
53.4 mg/g.
HPLC analysis of Mukia extract
The HPLC analysis showed different polyphenolic constitu-
ents with respect to different solvent extracts. The HPLC
chromatogram of chloroform extract was found to contain two
major peaks at 3 min and 23.1 min (Figure 1). The major
peaks at 3.0 min and at 23.1 min were identified as
phloroglucinol and quercetin, respectively, by comparing
their retention time and UV spectra with those of the
reference standards. The content of phloroglucinol and
quercetin was quantified as 1.3 and 16.1 mg/g, respectively,
of the dry material.
In vitro gluconeogenesis
Glucose production in the absence and presence of pyruvate
and in the presence of insulin is shown in Figure 2. In the
absence of pyruvate there was no glucose synthesis, whereas
glucose was synthesized in the presence of pyruvate at 30 min
0.57 mg/g glucose and at 60 min 1.2 mg/g. There was a linear
increase in the production of glucose with time. The
gluconeogenesis in the presence of insulin was inhibited,
but there was no significant difference between the inhibition
of gluconeogenesis in the presence of 1 U/ml and 2 U/ml of
insulin. Inhibition of gluconeogenesis by quercetin and
phloroglucinol in the absence and in the presence of 1 Unit
insulin is shown in Figure 3. Quercetin at 0.25 mg/ml
concentration inhibited gluconeogenesis completely in the
first 30 min, but in the subsequent 30 min, the inhibition was
overcome slightly. At 60 min, the amount of glucose produced
was 0.42 mg/g tissue (65% inhibition). In the presence of
insulin (1U/ml) along with quercetin (0.25 mg/ml), the
inhibition of gluconeogenesis was overcome by producing
0.22 mg/g glucose (61% inhibition) at 30 min. At 60 min, the
Figure 1. HPLC analysis of the chloroform extract of Mukia showing the presence of phloroglucinol and quercetin.
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amount of glucose produced was 0.44 mg/g glucose (63%
inhibition). At 0.5 mg/ml concentration, quercetin inhibited
gluconeogenesis completely in the first 30 min, but the
inhibition was slightly overcome at 60 min, resulting in the
production of 0.13 mg/g glucose (89% inhibition). In the
presence of insulin (1U/ml), at 30 min, 0.13 mg/g glucose
(76% inhibition) was produced, and at 60 min, 0.42 mg/g
(65% inhibition) glucose was produced when compared with
pyruvate alone. Thus, in the presence of insulin, quercetin did
not show any synergistic effect for the inhibition of
gluconeogenesis. At 0.25 mg/ml, phloroglucinol inhibited
gluconeogenesis completely at 30 min, and threrafter it
continued for 60 min also. There was no change in the
inhibition in the presence of insulin (1 U/ml) or when higher
concentration of phloroglucinol (0.5 mg/ml) was present.
Inhibition of gluconeogenesis by Mukia extract in
the presence and in the absence of 1 U insulin is shown in
Figure 4. In the presence of 0.25 mg/ml Mukia extract, there
was an initial inhibition of gluconeogenesis for the first
30 min producing 0.1 mg/g (82% inhibition) glucose.
At 60 min, the inhibition was overcome producing 0.65 mg/g
glucose (45% inhibition). In the presence of insulin (1U/ml),
the initial inhibition seen with the Mukia extract alone was
overcome by producing 0.48 mg/g glucose (15% inhibition),
but at 60 min, the gluconeogenesis was slightly inhibited
resulting in the production of 0.59 mg/g glucose (50%
inhibition). At 0.5 mg/ml concentration, Mukia extract did
not inhibit gluconeogenesis, instead it stimulated gluconeo-
genesis by 1.6-fold and 1.2-fold at 30 min and 60 min,
respectively, compared with pyruvate alone. However, in the
presence of insulin (1U/ml), it inhibited gluconeogenesis
resulting in the production of 0.12 mg/g (79% inhibition) and
0.13 mg/g glucose (89% inhibition) at 30 min and 60 min,
respectively, when compared with pyruvate alone. In the
presence of insulin, Mukia extract showed synergistic effect
on the inhibition of gluconeogenesis.
In vitro glucose uptake by isolated rat
hemi-diaphragm
The results of glucose uptake by isolated rat hemi-diaphragm
are shown in Table 1. Insulin caused stimulation of glucose
uptake (112.41 9.14 mg/dl/g/30 min) by isolated rat hemi-
diaphragm in comparison with the normal control
(101.29 9.24 mg/dl/g/30 min). This difference was signifi-
cant (p50.05). Mukia extract showed no significant increase
Figure 4. Inhibition of gluconeogenesis in rat liver by Mukia extract in
the absence and presence of 1 Unit of insulin. Gluconeogenesis in rat
liver was determined from pyruvate in the presence of 0.25 mg/ml and
0.5 mg/ml Mukia extract in the absence or presence of 1 U insulin
preincubated with liver slices prior to determining gluconeogenesis from
pyruvate (5 mM).
Figure 3. Inhibition of gluconeogenesis in rat liver by quercetin and
phloroglucinol in the absence and presence of 1 Unit of insulin.
Gluconeogenesis in rat liver was determined from pyruvate in the
presence of 0.25 mg/ml and 0.5 mg/ml of quercetin or phloroglucinol
preincubated with liver slices in the absence or presence of 1 Unit of
insulin prior to determining gluconeogenesis from pyruvate (5 mM).
Figure 2. Gluconeogenesis from pyruvate in rat liver. In vitro
gluconeogenesis in rat liver slices was tested in the absence and
presence of pyruvate (5 mM) and in the absence and presence of 1 and 2
Units of insulin. Results are mg of glucose formed/g of liver.
Table 1. In vitro glucose uptake by isolated rat hemi-diaphragm.
Group Glucose uptake (mg/dl/g/30 min)
Normal control 101.29 9.24*
Insulin control 112.41 9.14*
Mukia 50mg/ml 101.49 8.29
Mukia 100 mg/ml 99.16 12.72
InsulinþMukia 100 mg/ml 152.82 13.30*
Glucose uptake in the isolated rat hemi-diaphragm was carried out
in vitro as described in the Methods section. Values are expressed as
mean SD (n¼ 8). *Results are significantly different among groups
at p50.05.
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in the uptake of glucose at the two concentrations tested
(50 and 100 mg/ml). However, a combination of insulin and
100mg/ml of Mukia extract significantly (p50.05) poten-
tiated the action of insulin on glucose uptake
(152.82 13.30 mg/dl/g/30 min) when compared with the
insulin control (112.41 9.14 mg/dl/g/30 min).
Discussion
Phytochemicals are a diverse class of compounds derived
from different plant families but possessing similar func-
tions. Many phytochemicals and plant extracts have been
used in the treatment of type 2 diabetes. For example,
isoflavone from soy, condensed tannins from tea, and
phenolics from coffee have been tested for type 2 diabetes.
Nutritional intervention studies performed in animals and
humans suggest that ingestion of soy protein-associated
isoflavones improved glucose control and insulin sensitivity
(Hamden et al., 2011). Epigallocatechin-3-gallate (EGCG), a
green tea polyphenol, suppresses hepatic gluconeogenesis
through 50AMP-activated protein kinase (Collins et al.,
2007). Hisperedin, naringenin, genestein, and diadzein have
been shown to suppress gluconeogenic enzyme expression in
liver and hepatocytes in culture (Narender et al., 2011).
Polyphenol-like resveratrol has also been proposed as
a potential antidiabetic agent (Szkudelski & Szkudelska,
2011). In a recent study, it was observed that resveratrol
suppresses insulin signaling in adipocytes under insulin-
sensitive state, but enhances it in insulin-resistant cells
(Kang et al., 2012). In addition, extracts from berries have
also been shown to possess antidiabetic activity (Johnston
et al., 2005). Eriobotrya japonica (Thunb.) (Rosaceae) is
used to treat diabetes in folk traditional medicine for a long
time in China. A study of its antidiabetic activity in the total
flavonoid fractions showed the presence of flavonoids
having quercetin as their parent nuleus, such as quercetin-
3-O-rutinoside and quercetin-3-O-rhamnoside (Lu et al.,
2009).
Glucose is a fundamental source for cellular energy. It is
supplied through the diet and may be stored as glycogen in the
muscle and liver. During times of need, the glycogen is
degraded to release glucose. Although all tissue and cells
require glucose, about 50% of the glucose is used by the brain
in the post-absorptive state (De Fonzo, 2004). Glucose is also
endogenously produced mainly by the liver and to a small
extent by the kidneys (De Fonzo, 2004). The anaerobic
glycolytic products like lactate and pyruvate are the main
precursors for gluconeogenesis in the liver. Amino acids such
as alanine are also used for gluconeogenesis (Dong &
Freedland, 1980).
Insulin and glucagon are the main hormones regulating
glucose homeostasis. Although insulin is not needed for
glucose uptake in the liver, it is required for glucose uptake in
the peripheral tissues like muscle (Coomans et al., 2011;
Triplett, 2012). In diabetes, particularly in type 2 diabetes, the
insulin produced by the pancreas is unable to maintain glucose
homeostasis, and hence hypoglycemic agents have to be used
to reduce the levels of blood glucose (Wajchenberg, 2007).
In this in vitro study, we have investigated the ability of
phytochemicals such as quercetin, phloroglucinol, and Mukia
extract to inhibit gluconeogenesis in the rat liver and increase
glucose uptake by Mukia extract in rat hemi-diaphragm.
In vitro studies are useful in estimating the glucose metab-
olism since all the variables in the study can be controlled,
especially the influence of hormones such as insulin and
glucagon. We have shown that rat liver slices can convert
pyruvate to glucose and in the absence of pyruvate, very little
glucose was formed. Hence, the glucose present in the
reaction medium would have come from gluconeogenesis and
not from glycogen degradation. In the presence of insulin,
there was an inhibition of gluconeogenesis. However, no
significant difference was found between 1 U insulin and 2 U
insulin. This may be because of the effect of 1 U insulin that
could have been saturating, and hence additional insulin did
not show any significant difference.
Pyruvate-dependent gluconeogenesis involves converting
the pyruvate to phosphoenol pyruvate by the enzyme
phosphoenolpyruvate carboxykinase (PEPCK), which is
located in the cytosol. This may be the target of the
phytochemicals as well as the Mukia extract. However,
there is another pathway involving the mitochondrial
dicarboxylic acids in pyruvate-mediated gluconeogenesis.
Mukia extract and quercetin did not appear to inhibit
gluconeogenesis after the initial inhibition, whereas phlor-
oglucinol continued to inhibit gluconeogenesis suggesting
that it is a potent antidiabetic phytochemical. Mukia
(0.5 mg/ml) in the presence of 1 U insulin, on the other
hand, potentiated the action of insulin on inhibition of
gluconeogenesis. However, there was good synergestic effect
on the inhibition of gluconeogenesis in the presence of
insulin.
Isolated rat hemi-diaphragm is widely used as a model in
the study of glucose uptake and is a reliable method for
in vitro study of peripheral uptake of glucose. In our present
study of in vitro glucose uptake by isolated rat hemi-
diaphragm, Mukia extract by itself did not enhance glucose
uptake in the isolated rat hemi-diaphragm but in the presence
of 1 U insulin showed significantly (p50.05) higher level of
glucose uptake than the insulin-treated group, suggesting a
synergistic action. Such a synergestic action may also explain
why we observed a decreased inhibition of gluconeogenesis at
lower concentration of Mukia extract, but higher inhibition
when the Mukia concentration was increased in the presence
of insulin.
Altered glucose transport is associated with defective
Glut-4 translocation and impaired insulin signaling cascade
was evidenced as major defect in insulin resistance (Laville
et al., 1996). The ability of phytochemicals to enhance the
insulin sensitivity suggests that this may be a novel mechan-
isms to overcome insulin resistance.
Conclusion
Mukia maderaspatana extract has diverse antidiabetic effects
based on its ability to inhibit gluconeogenesis and potentiate
the action of insulin on glucose uptake. Plant phytochemicals,
which are rich in phenolics, have potent antidiabetic proper-
ties and they can replace the synthetic drugs, as they have no
proven side effects. Since Mukia is an edible plant, rich in
polyphenolics, traditional knowledge of its use in folk
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medicine for its antidiabetic properties offer a potential
therapeutic source for the treatment of diabetes. Mukia can be
used as a natural antidiabetic nutraceutical.
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